𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A case of rivastigmine toxicity caused by transdermal patch

✍ Scribed by Duk Hee Lee; Yoon Hee Choi; Kwang Hyun Cho; Soon Young Yun; Hyung Min Lee

Book ID
116195000
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
73 KB
Volume
29
Category
Article
ISSN
1532-8171

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Efficacy of rivastigmine transdermal pat
Efficacy of rivastigmine transdermal patch on activities of daily living: item responder analyses
✍ Gustavo Alva; George T. Grossberg; Frederick A. Schmitt; Xiangyi Meng; Jason T. πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 531 KB

In Alzheimer's disease (AD), rivastigmine has demonstrated statistically significant efficacy versus placebo on cognition and activities of daily living (ADL). The aim of this retrospective analysis was to further evaluate the treatment effects of rivastigmine on individual ADL items. Methods: This

A six-month double-blind, randomized, pl
A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patch versus capsule
✍ Bengt Winblad; Jeffrey Cummings; Niels Andreasen; George Grossberg; Marco Onofrj πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 231 KB

## Abstract ## Objectives To compare the efficacy, safety and tolerability of a novel rivastigmine transdermal patch with conventional rivastigmine capsules and placebo in patients with Alzheimer's disease (AD). ## Methods In this 24‐week, multicenter, double‐blind, double‐dummy, placebo‐ and ac